MedPath

Diagnostic Performance of Arterial Time for CT Assessment of Parietal Enhancement Defect for the Diagnosis of Ischemia in Mechanical Small Bowel Occlusions: a Comparative Study With Portal Time

Completed
Conditions
Bowel Obstruction Small
Registration Number
NCT04880421
Lead Sponsor
Fondation Hôpital Saint-Joseph
Brief Summary

Intestinal obstruction is a frequent cause of emergency room visits and represents about 4-7% of the causes of acute abdominal pain syndrome and up to 30% in adults over 60 years old.

Although 65 to 80% of patients are treated medically, small bowel obstruction remains a serious pathology, with a high mortality rate that can reach 25% in case of small bowel ischemia. It is necessary to systematically perform a CT scan in the initial workup of small bowel obstructions to confirm the diagnosis, identify the mechanism and detect signs of ischemia that would require emergency surgery.

The best sign for the diagnosis of ischemia is the defect or asymmetry of parietal enhancement of the dilated small bowel. In the literature, this sign is described almost exclusively at portal time. In case of suspicion of mesenteric ischemia (another serious pathology affecting the small bowel), it is recommended to perform an examination with three acquisitions (without injection, arterial time, and portal time).

The department's experience has shown that arterial time is sometimes more sensitive than portal time for visualizing a parietal enhancement defect of the small bowel in mechanical occlusions.

Very few studies have investigated the diagnostic performance of parietal enhancement asymmetry on arterial time in mechanical occlusions of the small bowel.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
158
Inclusion Criteria
  • Patient whose age is ≥ 18 years
  • Patient with a diagnosis of mechanical small bowel obstruction on CT performed between April 2014 and December 2019
  • Patient who had a CT scan with at least 3 phases: injection-free, arterial time, portal time
  • French-speaking patient
Exclusion Criteria
  • Patient who did not have surgery within the first 24 hours
  • Patient with a history of abdomino-pelvic surgery in the month preceding the scan
  • Patient under guardianship or curatorship
  • Patient deprived of liberty
  • Patient under court protection
  • Patient who objects to the use of his or her data for this research

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diagnostic performance of arterial versus portal phase in CT for the evaluation of parietal enhancement defectYear 1

This ouctome corresponds to the evaluation of the sensitivity, specificity, positive predictive value and negative predictive value of the acquisition for parietal enhancement defect as a sign of ischemia.

Secondary Outcome Measures
NameTimeMethod
Inter-observer reproducibility of parietal enhancement defect analysis at arterial timeYear 1

This outcome corresponds to the evaluation of the Kappa coefficient of inter-observer reproducibility.

Trial Locations

Locations (1)

Groupe Hospitalier Paris Saint-Joseph

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath